⌘K

Login Start Free

Home/Filings/4/0001572426-16-000236

4//SEC Filing

Nexvet Biopharma plc 4

Accession 0001572426-16-000236

CIK 0001618561operating

View on SEC.gov Company Profile

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 3:47 PM ET

Size

7.8 KB

Accession

0001572426-16-000236

Insider Transaction Report

Form 4

Period: 2016-09-30

Nexvet Biopharma plcNVET

Director

Transactions

Exercise/Conversion
Restricted Share Units
2016-09-30−500→ 1,500 total
Exercise: $0.13Exp: 2019-07-01→ Ordinary Shares (500 underlying)
Exercise/Conversion
Ordinary Shares
2016-09-30$0.13/sh+500$63→ 10,920 total

Holdings

Ordinary Shares
(indirect: By Trust)
1,500

Footnotes (1)

[F1]500 of the Restricted Share Units vested and became convertible on 9/30/16, and 500 Restricted Share Units shall vest and become convertible on each of 12/31/16, 3/31/17 and 6/30/17, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

Nexvet Biopharma plc

CIK 0001618561

Entity typeoperating

IncorporatedIreland

Related Parties

1

filerCIK 0001618561

Filing Metadata

Form type: 4
Filed: Oct 3, 8:00 PM ET
Accepted: Oct 4, 3:47 PM ET
Size: 7.8 KB

View on SEC.gov